Literature DB >> 27589484

Melasma.

Brian W Lee1, Robert A Schwartz1,2, Camila K Janniger3.   

Abstract

Melasma is a common acquired hypermelanosis that primarily affects women of skin type IV-VI. It tends to appear on sun-exposed areas of face and neck. The exact pathogenesis is linked with many factors include ultraviolet radiation, pregnancy, hormonal activity, thyroid abnormalities, and medications. Melasma, which involves increased melanin production and melanocytosis, may be principally epidermal, dermal, or mixed. Mainstays of treatment include topical hypopigmenting agents, lasers, chemical peels, and dermabrasion.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27589484     DOI: 10.23736/S0392-0488.16.05425-0

Source DB:  PubMed          Journal:  G Ital Dermatol Venereol        ISSN: 0392-0488            Impact factor:   2.011


  4 in total

Review 1.  A Meta-analysis-Based Assessment of Intense Pulsed Light for Treatment of Melasma.

Authors:  Jiarong Yi; Tao Hong; Hanling Zeng; Peiwen Li; Pinglu Li; Shaohua Wang; Jia Chen; Ping Li; Jianda Zhou
Journal:  Aesthetic Plast Surg       Date:  2020-02-13       Impact factor: 2.326

2.  Tranexamic Acid for Adults with Melasma: A Systematic Review and Meta-Analysis.

Authors:  Lei Zhang; Wei-Qiang Tan; Qing-Qing Fang; Wan-Yi Zhao; Qi-Ming Zhao; Jie Gao; Xiao-Wei Wang
Journal:  Biomed Res Int       Date:  2018-11-06       Impact factor: 3.411

3.  Upregulated Guanine Deaminase Is Involved in Hyperpigmentation of Seborrheic Keratosis via Uric Acid Release.

Authors:  Kyung Ah Cheong; In Sup Kil; Hyuk Wan Ko; Ai-Young Lee
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

4.  Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study.

Authors:  W G Philipp-Dormston; A Vila Echagüe; S H Pérez Damonte; J Riedel; A Filbry; K Warnke; C Lofrano; D Roggenkamp; G Nippel
Journal:  Int J Cosmet Sci       Date:  2020-08       Impact factor: 2.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.